AlphaCentric Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,500
Closed -$222K 283
2024
Q3
$222K Sell
3,500
-13,000
-79% -$823K 0.16% 126
2024
Q2
$875K Sell
16,500
-1,500
-8% -$79.5K 0.64% 55
2024
Q1
$1.48M Buy
+18,000
New +$1.48M 0.89% 42
2023
Q4
Sell
-60,000
Closed -$664K 283
2023
Q3
$664K Buy
+60,000
New +$664K 0.38% 80